Proteintech Expands Collaboration With Epigenetics Company Active Motif
08 sept. 2021 16h55 HE
|
Proteintech Group Inc.
ROSEMONT, Ill., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Proteintech Group, an original manufacturer of antibodies, nanobodies and recombinant proteins, today announced that it has made a strategic...
CRISPR and Cas Genes Markets, 2028 by Product & Service (Vector-based Cas, DNA-free Cas), Application (Biomedical, Agriculture)
16 juin 2021 06h08 HE
|
Research and Markets
Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The "CRISPR and Cas Genes Market Size, Share & Trends Analysis Report by Product & Service (Vector-based Cas, DNA-free Cas), by Application...
Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib
11 juin 2021 09h00 HE
|
Constellation Pharmaceuticals , Inc.
Translational data support the disease-modifying potential of pelabresibCentral pathology review confirmed bone marrow fibrosis improvements observed with pelabresib treatment Impact of pelabresib...
Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference
31 mai 2021 09h00 HE
|
Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., May 31, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover...
Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update
10 mai 2021 07h00 HE
|
Constellation Pharmaceuticals , Inc.
Dosing underway in the Phase 3 MANIFEST-2 clinical trialRecommended Phase 2 dose determined for CPI-0209 and first patient dosed in the Phase 2 expansion cohortsUpcoming data presentation at ASCO...
Constellation Pharmaceuticals to Host Conference Call to Discuss First Quarter 2021 Results
27 avr. 2021 11h30 HE
|
Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel...
MicroRNA Market Value Projected To Reach US$ 618.6 Million By 2027: Acumen Research And Consulting
06 avr. 2021 12h10 HE
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “MicroRNA Market– Global Industry Analysis, Market Size, Opportunities and Forecast,...
Global $4.75 Billion CRISPR & Cas Genes Market Analysis 2016-2019 & Forecasts 2020-2027
01 mars 2021 07h14 HE
|
Research and Markets
Dublin, March 01, 2021 (GLOBE NEWSWIRE) -- The "CRISPR & Cas Genes Market Size, Share & Trends Analysis Report, By Product & Service; By Application; By End Use; and By Region; Segment...
Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial Results
24 févr. 2021 07h00 HE
|
Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop...
Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
19 févr. 2021 16h00 HE
|
Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover...